Pierre Martinucci
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Base editing of β0-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies.
Journal: Science translational medicine
Published: November 26, 2025
Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the HBG1/2 promoters.
Journal: Molecular therapy. Nucleic acids
Published: October 08, 2025
Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease.
Journal: Cell reports. Medicine
Published: May 15, 2025
Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies.
Journal: Nucleic acids research
Published: January 10, 2025
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.
Journal: Molecular therapy. Nucleic acids
Published: July 30, 2022
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression.
Journal: Nature communications
Published: January 06, 2022
Contribution and evolution of blood culture quality indicators
Journal: Annales de biologie clinique
Published: June 21, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026